Naik, V.; Darandale, A.; Pal, P. Emerging Role of SGLT2 Inhibitors Beyond Glycemic Control: “Cardiovascular and Renal Benefits and Risks.” CARDIO 2026, 1 (1), 29-38. https://doi.org/10.64229/v3v43h95.